Your browser doesn't support javascript.
loading
Long-term safety of extended levonorgestrel-containing oral contraceptives in the United States.
Kaplan, Sigal; Bertoia, Monica L; Wang, Florence T; Zhou, Li; Lass, Amir; Evans, Alison; Dhanda, Sandeep; Roy, Debabrata; Seeger, John D.
Afiliación
  • Kaplan S; Global Pharmacovigilance, Teva Pharmaceutical Industries Ltd, Netanya, Israel. Electronic address: Sigal.Kaplan@teva.co.il.
  • Bertoia ML; Epidemiology, Optum, Boston, MA, USA.
  • Wang FT; Epidemiology, Optum, Boston, MA, USA.
  • Zhou L; Epidemiology, Optum, Boston, MA, USA.
  • Lass A; Theramex Ltd, London, UK.
  • Evans A; Drug Safety Research Unit, Southampton, UK; School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, UK.
  • Dhanda S; Drug Safety Research Unit, Southampton, UK; School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, UK.
  • Roy D; Drug Safety Research Unit, Southampton, UK; School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, UK.
  • Seeger JD; Epidemiology, Optum, Boston, MA, USA.
Contraception ; 105: 26-32, 2022 01.
Article en En | MEDLINE | ID: mdl-34599911

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Levonorgestrel / Tromboembolia Venosa Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans País/Región como asunto: America do norte Idioma: En Revista: Contraception Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Levonorgestrel / Tromboembolia Venosa Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans País/Región como asunto: America do norte Idioma: En Revista: Contraception Año: 2022 Tipo del documento: Article
...